These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 25471116

  • 21. Influence of dietary salts on the cardiovascular effects of low-dose combination of ramipril and felodipine in spontaneously hypertensive rats.
    Mervaala EM, Malmberg L, Teräväinen TL, Laakso J, Vapaatalo H, Karppanen H.
    Br J Pharmacol; 1998 Jan; 123(2):195-204. PubMed ID: 9489606
    [Abstract] [Full Text] [Related]

  • 22. Gliptin and GLP-1 analog treatment improves survival and vascular inflammation/dysfunction in animals with lipopolysaccharide-induced endotoxemia.
    Steven S, Hausding M, Kröller-Schön S, Mader M, Mikhed Y, Stamm P, Zinßius E, Pfeffer A, Welschof P, Agdauletova S, Sudowe S, Li H, Oelze M, Schulz E, Klein T, Münzel T, Daiber A.
    Basic Res Cardiol; 2015 Mar; 110(2):6. PubMed ID: 25600227
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Inhibitory Effects of Tofogliflozin on Cardiac Hypertrophy in Dahl Salt-Sensitive and Salt-Resistant Rats Fed a High-Fat Diet.
    Kimura T, Nakamura K, Miyoshi T, Yoshida M, Akazawa K, Saito Y, Akagi S, Ohno Y, Kondo M, Miura D, Wada J, Ito H.
    Int Heart J; 2019 May 30; 60(3):728-735. PubMed ID: 31105148
    [Abstract] [Full Text] [Related]

  • 26. N-Acetylcysteine improves renal dysfunction, ameliorates kidney damage and decreases blood pressure in salt-sensitive hypertension.
    Tian N, Rose RA, Jordan S, Dwyer TM, Hughson MD, Manning RD.
    J Hypertens; 2006 Nov 30; 24(11):2263-70. PubMed ID: 17053549
    [Abstract] [Full Text] [Related]

  • 27. Novel mechanism of angiotensin II-induced cardiac injury in hypertensive rats: the critical role of ASK1 and VEGF.
    Nako H, Kataoka K, Koibuchi N, Dong YF, Toyama K, Yamamoto E, Yasuda O, Ichijo H, Ogawa H, Kim-Mitsuyama S.
    Hypertens Res; 2012 Feb 30; 35(2):194-200. PubMed ID: 22089532
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjects.
    Sarashina A, Sesoko S, Nakashima M, Hayashi N, Taniguchi A, Horie Y, Graefe-Mody EU, Woerle HJ, Dugi KA.
    Clin Ther; 2010 Jun 30; 32(6):1188-204. PubMed ID: 20637971
    [Abstract] [Full Text] [Related]

  • 30. Effects of ACE inhibition on left ventricular failure and oxidative stress in Dahl salt-sensitive rats.
    Tsutsui H, Ide T, Hayashidani S, Kinugawa S, Suematsu N, Utsumi H, Takeshita A.
    J Cardiovasc Pharmacol; 2001 Jun 30; 37(6):725-33. PubMed ID: 11392469
    [Abstract] [Full Text] [Related]

  • 31. Pravastatin enhances beneficial effects of olmesartan on vascular injury of salt-sensitive hypertensive rats, via pleiotropic effects.
    Yamamoto E, Yamashita T, Tanaka T, Kataoka K, Tokutomi Y, Lai ZF, Dong YF, Matsuba S, Ogawa H, Kim-Mitsuyama S.
    Arterioscler Thromb Vasc Biol; 2007 Mar 30; 27(3):556-63. PubMed ID: 17170375
    [Abstract] [Full Text] [Related]

  • 32. [Linagliptin (Trajenta): a selective DPP-4 inhibitor with limited renal elimination].
    Scheen AJ, Van Gaal LF.
    Rev Med Liege; 2012 Feb 30; 67(2):91-7. PubMed ID: 22482239
    [Abstract] [Full Text] [Related]

  • 33. Possible involvement of aminopeptidase A in hypertension and renal damage in Dahl salt-sensitive rats.
    Nomura M, Nomura S, Mitsui T, Suzuki M, Kobayashi H, Ito T, Itakura A, Kikkawa F, Mizutani S.
    Am J Hypertens; 2005 Apr 30; 18(4 Pt 1):538-43. PubMed ID: 15831365
    [Abstract] [Full Text] [Related]

  • 34. Relaxin ameliorates salt-sensitive hypertension and renal fibrosis.
    Yoshida T, Kumagai H, Suzuki A, Kobayashi N, Ohkawa S, Odamaki M, Kohsaka T, Yamamoto T, Ikegaya N.
    Nephrol Dial Transplant; 2012 Jun 30; 27(6):2190-7. PubMed ID: 22086971
    [Abstract] [Full Text] [Related]

  • 35. Calcineurin inhibitor attenuates the development and induces the regression of cardiac hypertrophy in rats with salt-sensitive hypertension.
    Shimoyama M, Hayashi D, Zou Y, Takimoto E, Mizukami M, Monzen K, Kudoh S, Hiroi Y, Yazaki Y, Nagai R, Komuro I.
    Circulation; 2000 Oct 17; 102(16):1996-2004. PubMed ID: 11034951
    [Abstract] [Full Text] [Related]

  • 36. Excretion of the dipeptidyl peptidase-4 inhibitor linagliptin in rats is primarily by biliary excretion and P-gp-mediated efflux.
    Fuchs H, Runge F, Held HD.
    Eur J Pharm Sci; 2012 Apr 11; 45(5):533-8. PubMed ID: 22198311
    [Abstract] [Full Text] [Related]

  • 37. Effects of calcium sensitizer OR-1986 on a cardiovascular mortality and myocardial remodelling in hypertensive Dahl/Rapp rats.
    Louhelainen M, Merasto S, Finckenberg P, Vahtola E, Kaheinen P, Leskinen H, Levijoki J, Pollesello P, Haikala H, Mervaala EM.
    J Physiol Pharmacol; 2009 Sep 11; 60(3):41-7. PubMed ID: 19826180
    [Abstract] [Full Text] [Related]

  • 38. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
    Jackson EK, Dubinion JH, Mi Z.
    Clin Exp Pharmacol Physiol; 2008 Jan 11; 35(1):29-34. PubMed ID: 18047624
    [Abstract] [Full Text] [Related]

  • 39. Binding to dipeptidyl peptidase-4 determines the disposition of linagliptin (BI 1356)--investigations in DPP-4 deficient and wildtype rats.
    Retlich S, Withopf B, Greischel A, Staab A, Jaehde U, Fuchs H.
    Biopharm Drug Dispos; 2009 Nov 11; 30(8):422-36. PubMed ID: 19771584
    [Abstract] [Full Text] [Related]

  • 40. DPP-4 inhibition on top of angiotensin receptor blockade offers a new therapeutic approach for diabetic nephropathy.
    Alter ML, Ott IM, von Websky K, Tsuprykov O, Sharkovska Y, Krause-Relle K, Raila J, Henze A, Klein T, Hocher B.
    Kidney Blood Press Res; 2012 Nov 11; 36(1):119-30. PubMed ID: 23171828
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.